Emma is a senior lawyer who advises clients in all aspects of intellectual property protection, strategy, and enforcement.
Recognised by Legal 500 as a key lawyer for both 'Patents' and 'Trade Marks, Copyright and Design', Emma combines a robust technical background with a business-centred approach to a broad spectrum of IP issues. Emma's clients commend her as 'always on hand to provide considered and commercial advice', reflecting her commitment to distilling complex technical matters into practical solutions, enabling clients to navigate the intricacies of IP with confidence.
Emma's practice spans both contentious and non-contentious aspects of IP. On the non-contentious side of her practice, Emma is passionate about creative brand-building strategy and trade mark business education. From developing collaboration agreements to executing large scale anti-counterfeit operations, she loves to devise commercial strategies that safeguard brands and innovations, enhancing her clients' valuable IP assets.
When it comes to contentious IP, Emma has extensive experience coordinating and managing multi-jurisdictional IP disputes, shaping effective UK and pan-European litigation strategies across a range of IP types. With a strong foundation in both law and science, Emma handles a range of IP issues in the pharmaceuticals and life sciences sector, particularly in relation to patent validity and infringement, as well as freedom to operate.
Emma has a special interest in the consumer, health and pharmaceutical industries, and enjoys working with start-ups and social enterprises, as well as the firm's pro bono clients.
Experience & capabilities
Selected matters
- a global pharmaceutical company in a pan-European patent dispute relating to a blockbuster treatment for multiple sclerosis
- a well-known global sports apparel company in relation to the resolution of a complex trade mark dispute across UK and European markets
- a global beverage company on developing and executing an innovative anti-counterfeit strategy for a large trade mark portfolio, including the co-ordination of multi-jurisdiction investigations and enforcement actions across UK and EU
- Gilead Sciences on UK and European patent litigation in relation to its HIV treatment, bictegravir, including advice on doctrine of equivalents infringement in respect of the UK proceedings
- a social enterprise tech start-up on all aspects of their IP strategy, including brand best-practice, ownership of key copyright works, and protecting their highly valuable IP in the context of collaborations with client-partners
Background
Emma joined Herbert Smith Freehills Kramer in February 2018 from a large New Zealand law firm.
Emma graduated from The University of Auckland with a Bachelor of Laws (with honours) and a Bachelor of Science (majoring in chemistry).
Emma is admitted as a barrister and solicitor of the High Court of New Zealand.
